Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Obstetrics/Gynecology

RSS  

Articles

  • Research proves LARC methods are best — What happens now in practice?

    The next patient is a 16-year-old young mother who became pregnant at 14 when the condom broke during intercourse and no emergency contraception was used after the method failure.
  • Spice and Sugar: Curcumin and Type 2 DM

    Results of this year-long intervention trial suggest that an ethanolic extract of curcumin could, together with appropriate dietary and lifestyle changes, play a role in slowing the progression from prediabetes to type 2 diabetes.
  • Probiotics vs. Antibiotics for Prevention of UTIs: Inferiority Complex?

    In this non-inferiority clinical trial, 1-year prophylaxis with an oral lactobacilli probiotic combination proved less effective than trimethoprim-sulfamethoxazole for preventing recurrence of urinary tract infections in postmenopausal women. However, although women in the antibiotic group had a dramatic increase in antibiotic resistance, there was no increase noted in the probiotic group.
  • That Fish You Ate Might Protect Against Colorectal Cancer

    The consumption of fish, supplementation with fish oil, and their effects on cardiovascular and pain conditions are common headline-makers in the mainstream media as well as this publication. A more recent line of inquiry involves the effects of omega-3 fatty acids on tumorigenesis, cancer prevalence, and mortality.
  • Lycopene and Prostate Cancer: No Magic Bullet

    Prostate cancer is the most commonly diagnosed non-dermatologic cancer and the second leading cause of cancer-related death in U.S. men.1 Its etiology and predisposing factors are inadequately characterized, but probably include some combination of older age, north American and northern European residence (perhaps a diet-related issue), African American race, and genetic similarities within families.
  • Check OC stock for Sandoz packaging flaw

    Check your clinic storeroom for stock of the Sandoz oral contraceptive Introvale. The Princeton, NJ-based company issued a voluntary recall in June 2012 for 10 lots of the generic oral contraceptive following a recent report of a packaging flaw.
  • Contraceptive Technology Update August 2012 Issue in PDF

  • Newest research eyes shortened pill-free interval

    Research presented at the latest Clinical Meeting of the American College of Obstetricians and Gynecologists indicates that women using an oral contraceptive (OC) with a 26/2 dosing regimen had less severe hormone withdrawal-associated symptoms than those using a 21/7 pill.
  • Teen-agers get message on effective contraception

    Good news: According to a new analysis of National Survey of Family Growth (NSFG) data, researchers report an increase in the number of sexually experienced teens using highly effective contraceptive methods such as the intrauterine device, implant, pill, patch, ring, or injectable contraceptive.1
  • CT Updates

    Sign up for the free Aug. 29 webinar, "Risk Made Real: A Case-Based Approach to Addressing Risk in Contraception," sponsored by the Association of Reproductive Health Professionals (ARHP).